OctoPlus publishes prospectus for listing of shares issued on 18 December 2009
Click here to go to the webcast of OctoPlus' half-year results on Thursday 6 August at 10 AM CET
Click here to directly access OctoPlus' Annual Report 2008
OctoPlus has increased its fill & finish capacity by expanding its GMP facility
'OctoPlus is dedicated to the creation of dosage forms for biotech derived and small molecules for optimal pharmacotherapy.'
